Quick Overview: Vice Chair of Education Dr. Thomas J. Fahey, III To learn more about our Endocrine Oncology Program at Weill Cornell Medicine, please visit: ... A new FDA approval for triple-negative breast cancer means some patients can now skip chemotherapy.
Tom Fahey Md - Detailed Overview & Context
Vice Chair of Education Dr. Thomas J. Fahey, III To learn more about our Endocrine Oncology Program at Weill Cornell Medicine, please visit: ... A new FDA approval for triple-negative breast cancer means some patients can now skip chemotherapy. The bladder serves as a reservoir for byproducts of sulforaphane metabolism, including a variety of glutathione-derived ...
